| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LeonaBio, Inc. | CHIEF SCIENTIFIC OFFICER | Common Stock | 25,178 | $135,205 | $5.37 | 04 Mar 2026 | Direct |
| LeonaBio, Inc. | CHIEF SCIENTIFIC OFFICER | Restricted Stock Units | 0 | $32,907 | $0.5619 | 03 Mar 2026 | Direct |
| Athira Pharma, Inc. | CHIEF SCIENTIFIC OFFICER | Stock Option (Right to Buy) | 35,138 | 24 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LONA | LeonaBio, Inc. | 03 Mar 2026 | 3 | -$7,298 | 4 | CHIEF SCIENTIFIC OFFICER | 05 Mar 2026, 19:02 |
| ATHA | Athira Pharma, Inc. | 31 Dec 2025 | 4 | -$3,717 | 4 | CHIEF SCIENTIFIC OFFICER | 05 Jan 2026, 19:50 |
| ATHA | Athira Pharma, Inc. | 24 Dec 2025 | 1 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 29 Dec 2025, 16:15 |
| ATHA | Athira Pharma, Inc. | 30 Jun 2025 | 4 | -$190 | 4 | CHIEF SCIENTIFIC OFFICER | 02 Jul 2025, 16:35 |
| ATHA | Athira Pharma, Inc. | 03 Mar 2025 | 2 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 04 Mar 2025, 16:30 |
| ATHA | Athira Pharma, Inc. | 31 Dec 2024 | 4 | +$674 | 4 | CHIEF SCIENTIFIC OFFICER | 03 Jan 2025, 17:03 |
| ATHA | Athira Pharma, Inc. | 01 Oct 2024 | 2 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 03 Oct 2024, 19:10 |
| ATHA | Athira Pharma, Inc. | 03 Sep 2024 | 3 | +$5,208 | 4 | CHIEF SCIENTIFIC OFFICER | 05 Sep 2024, 19:49 |
| ATHA | Athira Pharma, Inc. | 14 Feb 2024 | 1 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 16 Feb 2024, 16:54 |
| ATHA | Athira Pharma, Inc. | 04 Jan 2024 | 4 | -$517 | 4/A | CHIEF SCIENTIFIC OFFICER | 16 Feb 2024, 16:32 |
| ATHA | Athira Pharma, Inc. | 04 Jan 2024 | 4 | -$517 | 4 | Chief Scientific Officer | 08 Jan 2024, 16:36 |
| ATHA | Athira Pharma, Inc. | 24 Mar 2023 | 2 | +$8,654 | 4 | Chief Scientific Officer | 27 Mar 2023, 16:57 |
| ATHA | Athira Pharma, Inc. | 19 Jan 2023 | 2 | +$1,800 | 4 | Executive VP, Research | 23 Jan 2023, 16:26 |
| ATHA | Athira Pharma, Inc. | 28 Oct 2022 | 2 | +$4,995 | 4 | Executive VP, Research | 31 Oct 2022, 20:17 |
| ATHA | Athira Pharma, Inc. | 22 Jun 2022 | 2 | -$7,032 | 4 | Executive VP, Research | 24 Jun 2022, 19:25 |
| ATHA | Athira Pharma, Inc. | 08 Jun 2022 | 3 | +$5,091 | 4 | Executive VP, Research | 10 Jun 2022, 17:53 |
| ATHA | Athira Pharma, Inc. | 18 Feb 2022 | 2 | +$3,751 | 4 | Executive VP, Research | 18 Feb 2022, 18:38 |
| ATHA | Athira Pharma, Inc. | 18 Jan 2022 | 2 | +$1,201 | 4 | Executive VP, Research | 20 Jan 2022, 16:24 |
| ATHA | Athira Pharma, Inc. | 08 Jun 2021 | 2 | +$3,278 | 4 | Vice President of Discovery | 09 Jun 2021, 17:39 |
| ATHA | Athira Pharma, Inc. | 18 May 2021 | 3 | +$5,951 | 4/A | Vice President of Discovery | 10 Jun 2021, 18:41 |